The role of the two TNF receptors in proliferation, NF-κB activation and discrimination between TNF and LTα signalling in the human myeloma cell line OH-2

Cytokine

Volumn 8, Issue 6, 1996, Pages 430-438

  Börset, Magne ^a   Medvedev, Andrei E ^a   Sundan, Anders ^a   Espevik, Terje ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

LT ; Myeloma; NF B; TNF; TNF receptors

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MYELOMA; MYELOMA CELL; PRIORITY JOURNAL;

EID: 0030176053     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0059     Document Type: Article

References (51)

1. 1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3669.
2. 2. Beutler B, Cerami A (1989) The biology of cachectin/ TNF - a primary mediator of the host response. Ann Rev Immunol 7:625-655.
3. 3. Fiers W (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199-212.
4. 4. Jacob CO, McDevitt HO (1989) Tumor necrosis factor-a in murine autoimmune "lupus" nephritis. Nature 331:356-358.
5. 5. Waage A, Aasen AO (1992) Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma. Immunol Rev 127:221-230.
6. 6. Lahdevirta J, Maury CP, Teppo AM, Repo H (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85:289-291.
7. 7. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel R (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 313: 724-729.
8. 8. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962.
9. 9. Hohmann H-P, Remy R, Poschl B, van Loon APGM (1990) Tumor necrosis factor-alpha and beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-κB at low receptor occupancy within minutes after receptor binding. J Biol Chem 265:15183-15188.
10. 10. Schoenfeld H-J, Poeschl B, Frey JR, Loetscher H, Hunziker W, Lustig A, Zulauf M (1991) Efficient purification of recombinant tumor necrosis factor-beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J Biol Chem 266:3863-3869.
11. 11. Loetscher H, Pan Y-CE, Lahm H-W, Gentz R, Brockhaus M, Tabuchi T, Lesslauer W (1990) Molecular cloning and expression of the human 55 kDa tumor necrosis factor receptor. Cell 61:351-359.
12. 12. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370.
13. 13. Dembic Z, Loetscher H, Gubler U, Pan YE, Lahm H, Gentz R, Brockhaus M, Lesslauer W (1990) Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231-237.
14. 14. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (Wash. DC) 248:1019-1023.
15. 15. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296.
16. 16. Tartaglia LA, Rothe M, Hu Y-F, Goeddel DV (1993) Tumor necrosis factor's cytotoxic activity is signalled by the p55 TNF receptor. Cell 73:213-216.
17. 17. Engelmann H, Holtmann H, Brakebusch C, Avni YS, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D (1990) Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 265:14497-14504.
18. 18. Espevik T, Brockhaus M, Loetscher H, Nonstad U, Shalaby R (1990) Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med 171:415-426.
19. 19. Kruppa G, Thoma B, Machleidt T, Weigmann K, Kronke M (1992) Inhibition of tumor necrosis factor (TNF)-mediated NF-kappa B activation by selective blockade of the human 55-kDa TNF receptor. J Immunol 148:3152-3157.
20. 20. Wong GWH, Tartaglia LA, Lee MS, Goeddel DV (1993) Antiviral activity of tumor necrosis factor (TNF) is signalled through the 55-kDa receptor, type I TNFR. J Immunol 149:3350-3353.
21. 21. Gehr G Gentz R, Brockhaus M, Loetscher H, Lesslauer W (1992) Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cells activation. J Immunol 149:911-917.
22. 22. Vandenabeele P, Declercq W, Vercammen D, Van de Craen M, Grooten J, Loetscher H, Brockhaus M, Lesslauer W, Fiers W (1992) Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med 176:1015-1024.
23. 23. Grell M, Scheurich P, Meager A, Pfizenmaier K (1993) TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 12:143-148.
24. 24. Bigda J, Beletsky I, Brakebusch C, Varfolomeev Y, Engelmann H, Bigda J, Holtmann H, Wallach D (1994) Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180:445-460.
25. 25. Medvedev AE, Sundan A, Espevik T (1994) Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol 24:2842-2849.
26. 26. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913.
27. 27. Laegreid A, Medvedev A, Nonstad U, Bombara M, Ranges G, Sundan A, Espevik T (1994) Tumor necrosis factor p75 mediates cell-specific activation of nuclear factor κB and induction of human cytomegalovirus enhancer. J Biol Chem 269:7785-7791.
28. 28. Mackay F, Loetscher H, Stauber D, Gehr G, Lesslauer W (1993) Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277-1286.
29. 29. Erikstein BK, Smeland EB, Blomhoff HK, Funderud S, Prydz K, Lesslauer W, Espevik T (1991) Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 21:1033-1037.
30. 30. Aggarwal BB (1992) Comparative analysis of the structure and function of TNF-alpha and TNF-beta. Immunol Ser 56: 61-78.
31. 31. Gray PW, Aggarwal BB, Beton CV, Bringman ST, Henzel WJ, Jarrett JA, Leung WD, Moffat B, Ng P, Svedersky LP, Palladino MA, Nedwin GE (1984) Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312:721-725.
32. 32. Oster W, Lindemann A, Horn S, Mertelsmann R, Herrmann F (1987) Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 70:1700-1703.
33. 33. Locksley RM, Heinzel F-P, Shepard HM, Agosti J, Eessalu TE, Aggarwal BB, Harlan JM (1987) Tumor necrosis factor-alpha and beta differ in their capacities to generate interleukin-1 release from human endothelial cells. J Immunol 139:1891-1895.
34. 34. Desch CE, Dobrina A, Aggarwal BB, Harlan JM (1990) Tumor necrosis factor-alpha exhibits greater proinflammatory activity than lymphotoxin in vitro. Blood 75:2030-2034.
35. 35. Andrews JS, Berger AE, Ware CF (1990) Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. J Immunol 144:2582-2591.
36. 36. Kircheis R, Milleck J, Korobko VG, Shingarova LN, Schmidt HE (1992) Differences in the biological activity of TNF-alpha and TNF-beta correlate with their different abilities for binding to the target cells. Eur Cytokine Network 3:381-390.
37. 37. Chaturvedi MM, LaPushin R, Aggarwal BB (1994) Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular responses. J Biol Chem 269:14575-14583.
38. 38. Estrov Z, Kurzrock R, Pocisk E, Pathak S, Kantarjian HM, Zipf TF, Harris D, Talpaz M, Aggarwal BB (1992) Lymphotoxin is an autocrine growth factor for Epstein-Barr Virus B cell lines. J Exp Med 177:763-774.
39. 39. Börset M, Waage A, Brekke OL, Helseth E (1994) TNF and IL-6 are potent growth factors for O H-2, a novel human myeloma cell line. Eur J Haematol 53:31-37.
40. 40. Kramer SM, Carver ME, Apperson SM (1986) Comparison of TNF-alpha and TNF-beta cytolytic biological activities in a serum-free bioassay. Lymphokine Research 5:S139-S143.
41. 41. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131.
42. 42. Liabakk N-B, Sundan A, Lien E, Laegreid A, Bombara MP, Ranges G, Espevik T (1993) The release of soluble p55 TNF receptor from U937 cells studied by a new p55 immunoassay. J Immunol Methods 163:145-154.
43. 43. Fraker PJ, Speck JC (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6 - tetrachloro - 3α, 6α diphenylglucouril. Biochem Biophys Res Comm 80:849.
44. 44. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 95:99-105.
45. 45. Dignam JD, Lebowitz RM, Roeder G (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 11:1475.
46. 46. Grimm S, Baueuerie P (1993) The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem J 290:297-308.
47. 47. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR (1992) The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-Å resolution. J Biol Chem 267:2119-2122.
48. 48. Iwamoto S, Shibuya I, Takeda K, Takeda M (1994) Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells. Biochem Biophys Res Comm 199:70-77.
49. 49. Paleolog EM, Delasalle S-AJ, Buurman WA, Feldmann M (1994) Functional activities of receptors for tumor necrosis factor-a on human vascular endothelial cells. Blood 84:2578-2590.
50. 50. Browning JL, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow EP, Hession G, O'Brine-Greco B, Foley SF, Ware CF (1993) Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72:847-856.
51. 51. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA (1994) A lymphotoxin-beta specific receptor. Science. 264:707-710.